SELLAS Life Sciences Group, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SLS | 4564.T | LKFT | IDYA | RCUS | BINV.ST | |
|---|---|---|---|---|---|---|
| Market cap | 1.85B | 6.94B | 2.25B | 3.12B | 2.43B | 246.77M |
| P/E (TTM) | — | — | 3.2 | — | — | — |
| Forward P/E | -91.4 | -0.8 | -28.6 | -7.9 | -6.2 | -1.0 |
| Price/book | 13.4 | 3.0 | 12.2 | 2.9 | 3.8 | 1.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +464.20% | −26.09% | +9.26% | +8.41% | −1.28% | −88.73% |
| Today | +3.04% | 0.00% | +6.03% | +3.29% | +2.12% | +4.60% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All SLS news ›SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets
Shares of Sellas Life Sciences (SLS) snapped a four-day losing streak on Tuesday as retail investors looked ahead to abstracts from the American Society of Hematology (ASH), while fresh filings revealed increased holdings by Swiss asset…
SLS Stock Is Falling, But Retail Chatter Is Soaring – And One Investment Firm Hiked Its Stake Over 400% In Q3
Sellas Life Sciences (SLS) shares hit their lowest level in more than a month on Monday, with retail bulls buying the dip ahead of cancer data as fresh disclosures showed several investment firms had increased their third-quarter holdings…
SLS Stock Hits Over 1-Month Low: Retail Bulls Double Down Before Cancer Data — Fresh Filings Show Q3 Stake Hikes Of Over 400%
Sellas Life Sciences (SLS) shares hit their lowest level in more than a month on Monday, with retail bulls buying the dip ahead of cancer data as fresh disclosures showed several investment firms had increased their third-quarter holdings…
Sellas Life Sciences falls -13.1%
Sellas Life Sciences (SLS) is down -13.1%, or -$1.49 to $9.85. Published first on TheFly – the ultimate source for real-time, market-moving bre... Sellas Life Sciences falls -13.1% Sellas Life Sciences (SLS) is down -13.1%, or -$1.49 to…
Sellas Life Sciences: The Longer The Wait, The More Likely A REGAL Failure
Sellas Life Sciences remains a 'Strong Sell,' as the REGAL trial delay signals increased risk of failure and diminished probability of success. Learn more about SLS stock here. - Sellas Life Sciences remains a 'Strong Sell,' as the REGAL…
SELLAS Life Sciences Stock Falls 17% After Announcement Of Phase 3 REGAL Trial Milestone
Shares of SELLAS Life Sciences Group, Inc. (SLS) are falling 17 percent on Wednesday morning after the company announced that the pivotal Phase 3 REGAL trial evaluating galinpepimut-S in patients with acute myeloid leukemia has reached the…
Sellas falls as REGAL trial nears final analysis
SELLAS Life Sciences (SLS) stock fell as the company hits a final analysis milestone in its Phase 3 REGAL trial, setting up a topline data readout. Read more here. Shares of SELLAS Life Sciences (SLS) fell sharply on Wednesday after the…
SELLAS Life Sciences Reaches 80th Event in Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia
- Reaching the Pre-Specified 80th Event Triggers the Final Analysis of the Pivotal Phase 3 Trial - - Company to Report Topline Primary Endpoint Results this Quarter - About Phase 3 REGAL Trial The Phase 3 REGAL trial (NCT04229979) is a…
TriSalus Life Sciences, Inc. Stock (TLSI) - Quote Nasdaq
TriSalus Life Sciences, Inc. is an oncology-focused medical technology company. It is seeking to transform outcomes for patients with solid tumors by integrating its delivery technology with standard-of-care therapies, and with its…
SELLAS Life Sciences Group, Inc. $SLS Stock: Vision Financial Markets LLC Raises Holdings
Posted by Sarita Garza on Oct 24th, 2026 Check Out Our Latest Stock Report on SLS SELLAS Life Sciences Group (NASDAQ:SLS – Get Free Report) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.05)…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktwits.com4
- markets.businessinsider.com3
- tradingview.com3
- seekingalpha.com2
- themarketsdaily.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 19 articles, not a forecast.